The Cannabis Analytical Conundrum
Recently several states have legalized recreational and medical marijuana. This has created a confusing set of circumstances due to legalization at the state level, but cannabis is still an illegal schedule 1 drug at the federal level. This confusion also affects the development of analytical methods because there are no clear guidelines available to laboratories. This whitepaper will discuss the following topics: • Overview of state analytical requirements • Discussion of analytical method development for cannabinoids and related compounds of interest • Discussion of method performance
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
